HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of heart failure with pulmonary hypertension.

Abstract
Heart failure (HF) and pulmonary hypertension (PH) coexist frequently and contribute to each other. Because PH often is an insidious disease, the cornerstone of management is the early identification and treatment of its underlying causes, such as left-sided heart disease, left to right shunts, and pulmonary disorders. A practical clinical classification has been proposed by the Third World Symposium on Pulmonary Arterial Hypertension for the purpose of diagnosis and treatment of PH. Thromboembolic pulmonary hypertension should always be considered. Recent studies using vasodilators such as prostacyclins and endothelin antagonists give new hope in the otherwise poor prognosis of idiopathic pulmonary arterial hypertension and its related conditions. Despite optimum medical management, transplantation (lung/heart-lung) remains the choice in severely symptomatic patients.
AuthorsMohammed Najeeb Osman, Mark E Dunlap
JournalCurrent cardiology reports (Curr Cardiol Rep) Vol. 7 Issue 3 Pg. 196-203 (May 2005) ISSN: 1523-3782 [Print] United States
PMID15865861 (Publication Type: Journal Article, Review)
Topics
  • Heart Failure (complications, therapy)
  • Humans
  • Hypertension, Pulmonary (complications, diagnosis, therapy)
  • Patient Care Management
  • Prognosis
  • Ventricular Dysfunction, Left (complications, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: